Evaluation of oral Selenium Sulfide effect on treatment of Refractory Obsessive Compulsive Disorder in a Randomized Double Blind Placebo-Controlled Clinical Trial
Phase 3
- Conditions
- obsessive compulsive disorder.Obsessive-compulsive disorder
- Registration Number
- IRCT20180212038699N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Age between 18 to 62 years
Minimum score of Yale brown questionnaire should be 21
Obtaining written informed consent before entering into the study
use fluoxetine 20 mg once a day
Exclusion Criteria
Pregnancy
Internal diseases (diabetic patients , hypertension & ...)
Psychotic patients and mood disorders and neurology diseases
Thinking about suicide
Addiction to alcohol and narcotics
IQ below 80
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Obsession and compulsion score in Yale–Brown Obsessive Compulsive Scale (Y-BOCS). Timepoint: measurement yale brown questionnaire score in the began of first week and in the end of sixth week. Method of measurement: yale brown questionnaire.
- Secondary Outcome Measures
Name Time Method